Dr. Tyler James Sheetz, MD

Dr. Sheetz practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Sheetz's NPI, 1447757364, was assigned on April 8, 2018. Dr. Sheetz graduated from Ohio State College of Medicine in 2018. Dr. Sheetz holds California license A183608.

Dr. Sheetz's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Sheetz's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Sheetz is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sheetz practices. Vendor and product names are available with a free account.

Urology is Dr. Sheetz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Sheetz's licenses on file in 2 states: California and Ohio.

Dmand AI lists enlarged prostate, kidney stone disease, urinary endoscopy and urine flow blockage among the conditions Dr. Sheetz treats.

CMS data shows 129 Medicare services from Dr. Sheetz across 4 procedure codes in 2024, for 110 Medicare patients. Medicare paid $11,587 for them.

CMS counts 110 Medicare patients who saw Dr. Sheetz in 2024. The largest group is 65 to 74, with 54 patients. 72% of them have high blood pressure, and 67% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sheetz's median patient age at 68, with 27% women.

In 2024, Dr. Sheetz wrote 533 Medicare Part D claims for 182 patients. 92% of them were for generic drugs. CMS names the drug for 407 of them, across 12 drugs with 11 or more claims each, at $22,107 in total drug cost. In 2023, CMS named 57 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Sheetz for performance year 2024, reported as part of a group. Dr. Sheetz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sheetz as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Sheetz, published from 2015 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Prostate-Specific Antigen, Prostatic Neoplasms and Cell Line, Tumor. Dr. Sheetz has published most often in Cancers (Basel). Dr. Sheetz's most frequent co-authors are Shawn Dason, MD, Alireza Aminsharifi, MD and Seth K. Bechis, MD.

CMS Open Payments shows 41 general payments to Dr. Sheetz from 7 drug and device companies from 2021 to 2025. Grants make up the largest share, 89% of the total. Boston Scientific Corporation paid the most, $26,067.

Dr. Sheetz graduated from Ohio State College of Medicine in 2018.

Dr. Sheetz is in network with 13 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.